Diagnostic Consistency of GLIM and PG-SGA for Malnutrition in Pancreatic Cancer (NCT07057895) | Clinical Trial Compass
CompletedNot Applicable
Diagnostic Consistency of GLIM and PG-SGA for Malnutrition in Pancreatic Cancer
China108 participantsStarted 2023-01-01
Plain-language summary
This study aimed to evaluate the diagnostic consistency between the Global Leadership Initiative on Malnutrition (GLIM) criteria and the Patient-Generated Subjective Global Assessment (PG-SGA) for identifying malnutrition in patients with pancreatic malignant tumors. The goal is to determine if the GLIM criteria, a newer and more streamlined tool, shows substantial agreement with the well-established PG-SGA, thereby supporting its use in this high-risk clinical population.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Histopathologically confirmed pancreatic malignant tumor.
* Age ≥ 18 years.
* Clear cognition and ability to communicate verbally.
* Nutritional Risk Screening 2002 (NRS 2002) score ≥ 3.
* Provision of written informed consent to participate.
Exclusion Criteria:
* Presence of severe cardiac, hepatic, or renal comorbidities.
* Bedridden status precluding weight measurement.
* Contraindications to bioelectrical impedance analysis (e.g., implanted electronic devices, amputation).
* Concurrent diagnosis of other malignant tumors, particularly of the digestive system.
* Inability to cooperate with questionnaire completion or assessments.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Diagnostic Consistency between GLIM Criteria and PG-SGA
Timeframe: Assessed once within 24 hours of hospital admission.
Trial details
NCT IDNCT07057895
SponsorThe First Hospital of Hebei Medical University